Bessemer Group Inc Profound Medical Corp. Transaction History

Bessemer Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$8.16 - $11.33 $1,346 - $1,869	-165 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$13.6 - $17.88 $6,800 - $8,940	-500 Reduced 75.19%	165 $2,000
Q2 2021 Aug 06, 2021	SELL	$16.0 - $20.59 $12,800 - $16,472	-800 Reduced 54.61%	665 $11,000
Q1 2021 May 13, 2021	SELL	$19.16 - $28.09 $2,586 - $3,792	-135 Reduced 8.44%	1,465 $29,000
Q4 2020 Feb 09, 2021	SELL	$16.4 - $22.9 $13,119 - $18,320	-800 Reduced 33.33%	1,600 $33,000
Q3 2020 Nov 12, 2020	SELL	$14.05 - $18.13 $11,240 - $14,504	-800 Reduced 25.0%	2,400 $42,000
Q2 2020 Aug 05, 2020	BUY	$9.41 - $16.94 $30,112 - $54,208	3,200 New	3,200 $54,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.